{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T08:15:43Z","timestamp":1788336943190,"version":"build-2803163510"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,4,11]],"date-time":"2014-04-11T00:00:00Z","timestamp":1397174400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1038\/pr.2014.46","type":"journal-article","created":{"date-parts":[[2014,4,11]],"date-time":"2014-04-11T12:14:46Z","timestamp":1397218486000},"page":"72-80","source":"Crossref","is-referenced-by-count":17,"title":["High-dose IgG therapy mitigates bile duct\u2013targeted inflammation and obstruction in a mouse model of biliary atresia"],"prefix":"10.1038","volume":"76","author":[{"given":"Erika K.","family":"Fenner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juri","family":"Boguniewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca M.","family":"Tucker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald J.","family":"Sokol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cara L.","family":"Mack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,4,11]]},"reference":[{"key":"BFpr201446_CR1","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1053\/j.sempedsurg.2012.05.010","volume":"21","author":"M Davenport","year":"2012","unstructured":"Davenport M . Biliary atresia: clinical aspects. Semin Pediatr Surg 2012;21:175\u201384.","journal-title":"Semin Pediatr Surg"},{"key":"BFpr201446_CR2","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1097\/MPG.0b013e318282a913","volume":"56","author":"C Jimenez-Rivera","year":"2013","unstructured":"Jimenez-Rivera C, Jolin-Dahel KS, Fortinsky KJ, Gozdyra P, Benchimol EI . International incidence and outcomes of biliary atresia. J Pediatr Gastroenterol Nutr 2013;56:344\u201354.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"BFpr201446_CR3","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/petr.12040","volume":"17","author":"A Gallo","year":"2013","unstructured":"Gallo A, Esquivel CO . Current options for management of biliary atresia. Pediatr Transplant 2013;17:95\u20138.","journal-title":"Pediatr Transplant"},{"key":"BFpr201446_CR4","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/1750-1172-8-128","volume":"8","author":"C Petersen","year":"2013","unstructured":"Petersen C, Davenport M . Aetiology of biliary atresia: what is actually known? Orphanet J Rare Dis 2013;8:128.","journal-title":"Orphanet J Rare Dis"},{"key":"BFpr201446_CR5","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1146\/annurev-med-042909-093734","volume":"62","author":"K Bessho","year":"2011","unstructured":"Bessho K, Bezerra JA . Biliary atresia: will blocking inflammation tame the disease? Annu Rev Med 2011;62:171\u201385.","journal-title":"Annu Rev Med"},{"key":"BFpr201446_CR6","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1055\/s-0032-1329899","volume":"32","author":"CL Mack","year":"2012","unstructured":"Mack CL, Feldman AG, Sokol RJ . Clues to the etiology of bile duct injury in biliary atresia. Semin Liver Dis 2012;32:307\u201316.","journal-title":"Semin Liver Dis"},{"issue":"4 Pt 1","key":"BFpr201446_CR7","first-page":"394","volume":"33","author":"M Riepenhoff-Talty","year":"1993","unstructured":"Riepenhoff-Talty M, Schaekel K, Clark HF, et al. Group A rotaviruses produce extrahepatic biliary obstruction in orally inoculated newborn mice. Pediatr Res 1993;33(4 Pt 1):394\u20139.","journal-title":"Pediatr Res"},{"key":"BFpr201446_CR8","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1203\/01.PDR.0000130480.51066.FB","volume":"56","author":"CL Mack","year":"2004","unstructured":"Mack CL, Tucker RM, Sokol RJ, et al. Biliary atresia is associated with CD4+ Th1 cell-mediated portal tract inflammation. Pediatr Res 2004;56:79\u201387.","journal-title":"Pediatr Res"},{"key":"BFpr201446_CR9","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.clim.2005.01.012","volume":"115","author":"CL Mack","year":"2005","unstructured":"Mack CL, Tucker RM, Sokol RJ, Kotzin BL . Armed CD4+ Th1 effector cells and activated macrophages participate in bile duct injury in murine biliary atresia. Clin Immunol 2005;115:200\u20139.","journal-title":"Clin Immunol"},{"key":"BFpr201446_CR10","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1172\/JCI200421153","volume":"114","author":"P Shivakumar","year":"2004","unstructured":"Shivakumar P, Campbell KM, Sabla GE, et al. Obstruction of extrahepatic bile ducts by lymphocytes is regulated by IFN-\u03b3 in experimental biliary atresia. J Clin Invest 2004;114:322\u20139.","journal-title":"J Clin Invest"},{"key":"BFpr201446_CR11","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1002\/hep.21366","volume":"44","author":"CL Mack","year":"2006","unstructured":"Mack CL, Tucker RM, Lu BR, et al. Cellular and humoral autoimmunity directed at bile duct epithelia in murine biliary atresia. Hepatology 2006;44:1231\u20139.","journal-title":"Hepatology"},{"key":"BFpr201446_CR12","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.autrev.2006.10.004","volume":"6","author":"B Terrier","year":"2007","unstructured":"Terrier B, Degand N, Guilpain P, Servettaz A, Guillevin L, Mouthon L . Alpha-enolase: a target of antibodies in infectious and autoimmune diseases. Autoimmun Rev 2007;6:176\u201382.","journal-title":"Autoimmun Rev"},{"key":"BFpr201446_CR13","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1053\/j.gastro.2010.07.042","volume":"139","author":"BR Lu","year":"2010","unstructured":"Lu BR, Brindley SM, Tucker RM, Lambert CL, Mack CL . a-enolase autoantibodies cross-reactive to viral proteins in a mouse model of biliary atresia. Gastroenterology 2010;139:1753\u201361.","journal-title":"Gastroenterology"},{"key":"BFpr201446_CR14","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1002\/hep.25662","volume":"56","author":"CS Lages","year":"2012","unstructured":"Lages CS, Simmons J, Chougnet CA, Miethke AG . Regulatory T cells control the CD8 adaptive immune response at the time of ductal obstruction in experimental biliary atresia. Hepatology 2012;56:219\u201327.","journal-title":"Hepatology"},{"key":"BFpr201446_CR15","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1002\/hep.24807","volume":"55","author":"SM Brindley","year":"2012","unstructured":"Brindley SM, Lanham AM, Karrer FM, Tucker RM, Fontenot AP, Mack CL . Cytomegalovirus-specific T-cell reactivity in biliary atresia at the time of diagnosis is associated with deficits in regulatory T cells. Hepatology 2012;55:1130\u20138.","journal-title":"Hepatology"},{"key":"BFpr201446_CR16","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.jhep.2013.05.010","volume":"59","author":"RM Tucker","year":"2013","unstructured":"Tucker RM, Feldman AG, Fenner EK, Mack CL . Regulatory T cells inhibit Th1 cell-mediated bile duct injury in murine biliary atresia. J Hepatol 2013;59:790\u20136.","journal-title":"J Hepatol"},{"key":"BFpr201446_CR17","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1056\/NEJMra993360","volume":"345","author":"MD Kazatchkine","year":"2001","unstructured":"Kazatchkine MD, Kaveri SV . Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin. N Engl J Med 2001;345:747\u201355.","journal-title":"N Engl J Med"},{"key":"BFpr201446_CR18","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s281-001-8170-y","volume":"23","author":"L Rauova","year":"2001","unstructured":"Rauova L, Rovensky J, Shoenfeld Y . Immunomodulation of autoimmune diseases by high-dose intravenous immunoglobulins. Springer Semin Immunopathol 2001;23:447\u201357.","journal-title":"Springer Semin Immunopathol"},{"key":"BFpr201446_CR19","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1056\/NEJMra1009433","volume":"367","author":"EW Gelfand","year":"2012","unstructured":"Gelfand EW . Intravenous immune globulin in autoimmune and inflammatory diseases. N Engl J Med 2012;367:2015\u201325.","journal-title":"N Engl J Med"},{"key":"BFpr201446_CR20","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1126\/science.291.5503.484","volume":"291","author":"A Samuelsson","year":"2001","unstructured":"Samuelsson A, Towers TL, Ravetch JV . Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor. Science 2001;291:484\u20136.","journal-title":"Science"},{"key":"BFpr201446_CR21","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.jneuroim.2006.04.011","volume":"176","author":"KY Zhu","year":"2006","unstructured":"Zhu KY, Feferman T, Maiti PK, Souroujon MC, Fuchs S . Intravenous immunoglobulin suppresses experimental myasthenia gravis: immunological mechanisms. J Neuroimmunol 2006;176:187\u201397.","journal-title":"J Neuroimmunol"},{"key":"BFpr201446_CR22","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0022-3565(24)29273-9","volume":"299","author":"C Kishimoto","year":"2001","unstructured":"Kishimoto C, Takada H, Kawamata H, Umatake M, Ochiai H . Immunoglobulin treatment prevents congestive heart failure in murine encephalomyocarditis viral myocarditis associated with reduction of inflammatory cytokines. J Pharmacol Exp Ther 2001;299:645\u201351.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFpr201446_CR23","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1006\/jaut.2000.0433","volume":"15","author":"A Achiron","year":"2000","unstructured":"Achiron A, Mor F, Margalit R, Cohen IR, Lider O, Miron S . Suppression of experimental autoimmune encephalomyelitis by intravenously administered polyclonal immunoglobulins. J Autoimmun 2000;15:323\u201330.","journal-title":"J Autoimmun"},{"issue":"Suppl 1","key":"BFpr201446_CR24","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1007\/s10875-010-9394-5","volume":"30","author":"MS Maddur","year":"2010","unstructured":"Maddur MS, Othy S, Hegde P, et al. Immunomodulation by intravenous immunoglobulin: role of regulatory T cells. J Clin Immunol 2010;30:Suppl 1:S4\u20138.","journal-title":"J Clin Immunol"},{"key":"BFpr201446_CR25","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/0167-5699(93)90267-O","volume":"14","author":"AJ Gearing","year":"1993","unstructured":"Gearing AJ, Newman W . Circulating adhesion molecules in disease. Immunol Today 1993;14:506\u201312.","journal-title":"Immunol Today"},{"key":"BFpr201446_CR26","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1172\/JCI117012","volume":"93","author":"A Achiron","year":"1994","unstructured":"Achiron A, Margalit R, Hershkoviz R, et al. Intravenous immunoglobulin treatment of experimental T cell-mediated autoimmune disease. Upregulation of T cell proliferation and downregulation of tumor necrosis factor alpha secretion. J Clin Invest 1994;93:600\u20135.","journal-title":"J Clin Invest"},{"issue":"Suppl 1","key":"BFpr201446_CR27","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/cei.1996.104.s1.10","volume":"104","author":"J Andersson","year":"1996","unstructured":"Andersson J, Skans\u00e9n-Saphir U, Sparrelid E, Andersson U . Intravenous immune globulin affects cytokine production in T lymphocytes and monocytes\/macrophages. Clin Exp Immunol 1996;104:Suppl 1:10\u201320.","journal-title":"Clin Exp Immunol"},{"key":"BFpr201446_CR28","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1093\/intimm\/13.12.1551","volume":"13","author":"RJ Ober","year":"2001","unstructured":"Ober RJ, Radu CG, Ghetie V, Ward ES . Differences in promiscuity for antibody-FcRn interactions across species: implications for therapeutic antibodies. Int Immunol 2001;13:1551\u20139.","journal-title":"Int Immunol"},{"key":"BFpr201446_CR29","doi-asserted-by":"publisher","first-page":"4826","DOI":"10.1074\/jbc.M109.081828","volume":"285","author":"JT Andersen","year":"2010","unstructured":"Andersen JT, Daba MB, Berntzen G, Michaelsen TE, Sandlie I . Cross-species binding analyses of mouse and human neonatal Fc receptor show dramatic differences in immunoglobulin G and albumin binding. J Biol Chem 2010;285:4826\u201336.","journal-title":"J Biol Chem"},{"key":"BFpr201446_CR30","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1177\/030098589703400113","volume":"34","author":"CS Elangbam","year":"1997","unstructured":"Elangbam CS, Qualls CW Jr, Dahlgren RR . Cell adhesion molecules\u2013update. Vet Pathol 1997;34:61\u201373.","journal-title":"Vet Pathol"},{"key":"BFpr201446_CR31","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1002\/hep.1840150216","volume":"15","author":"R Volpes","year":"1992","unstructured":"Volpes R, Van Den Oord JJ, Desmet VJ . Vascular adhesion molecules in acute and chronic liver inflammation. Hepatology 1992;15:269\u201375.","journal-title":"Hepatology"},{"key":"BFpr201446_CR32","first-page":"263","volume":"145","author":"P Dillon","year":"1994","unstructured":"Dillon P, Belchis D, Tracy T, Cilley R, Hafer L, Krummel T . Increased expression of intracellular adhesion molecules in biliary atresia. The Amer J Pathol 1994;145:263\u20137.","journal-title":"The Amer J Pathol"},{"key":"BFpr201446_CR33","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1053\/jpsu.2001.25798","volume":"36","author":"H Kobayashi","year":"2001","unstructured":"Kobayashi H, Horikoshi K, Long L, Yamataka A, Lane GJ, Miyano T . Serum concentration of adhesion molecules in postoperative biliary atresia patients: relationship to disease activity and cirrhosis. J Pediatr Surg 2001;36:1297\u2013301.","journal-title":"J Pediatr Surg"},{"key":"BFpr201446_CR34","doi-asserted-by":"publisher","first-page":"e19910","DOI":"10.1371\/journal.pone.0019910","volume":"6","author":"SJ Patel","year":"2011","unstructured":"Patel SJ, Jindal R, King KR, Tilles AW, Yarmush ML . The inflammatory response to double stranded DNA in endothelial cells is mediated by NF?B and TNFa. PLoS ONE 2011;6:e19910.","journal-title":"PLoS ONE"},{"key":"BFpr201446_CR35","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1196\/annals.1361.113","volume":"1051","author":"S Skurkovich","year":"2005","unstructured":"Skurkovich S, Skurkovich B . Anticytokine therapy, especially anti-interferon-gamma, as a pathogenetic treatment in TH-1 autoimmune diseases. Ann N Y Acad Sci 2005;1051:684\u2013700.","journal-title":"Ann N Y Acad Sci"},{"key":"BFpr201446_CR36","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1182\/blood.V100.5.1774.h81702001774_1774_1779","volume":"100","author":"A Mouzaki","year":"2002","unstructured":"Mouzaki A, Theodoropoulou M, Gianakopoulos I, Vlaha V, Kyrtsonis MC, Maniatis A . Expression patterns of Th1 and Th2 cytokine genes in childhood idiopathic thrombocytopenic purpura (ITP) at presentation and their modulation by intravenous immunoglobulin G (IVIg) treatment: their role in prognosis. Blood 2002;100:1774\u20139.","journal-title":"Blood"},{"key":"BFpr201446_CR37","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.1172\/JCI116862","volume":"92","author":"M Svenson","year":"1993","unstructured":"Svenson M, Hansen MB, Bendtzen K . Binding of cytokines to pharmaceutically prepared human immunoglobulin. J Clin Investigat 1993:92:2533\u201339.","journal-title":"J Clin Investigat"},{"key":"BFpr201446_CR38","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1182\/blood.V90.6.2376","volume":"90","author":"C Ross","year":"1997","unstructured":"Ross C, Svenson M, Nielsen H, Lundsgaard C, Hansen MB, Bendtzen K . Increased in vivo antibody activity against interferon alpha, interleukin-1alpha, and interleukin-6 after high-dose Ig therapy. Blood 1997;90:2376\u201380.","journal-title":"Blood"},{"key":"BFpr201446_CR39","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1172\/JCI117881","volume":"95","author":"C Ross","year":"1995","unstructured":"Ross C, Svenson M, Hansen MB, Vejlsgaard GL, Bendtzen K . High avidity IFN-neutralizing antibodies in pharmaceutically prepared human IgG. J Clin Invest 1995;95:1974\u20138.","journal-title":"J Clin Invest"},{"key":"BFpr201446_CR40","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1182\/blood-2007-03-079947","volume":"111","author":"A Ephrem","year":"2008","unstructured":"Ephrem A, Chamat S, Miquel C, et al. Expansion of CD4+CD25+ regulatory T cells by intravenous immunoglobulin: a critical factor in controlling experimental autoimmune encephalomyelitis. Blood 2008;111:715\u201322.","journal-title":"Blood"}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/pr201446.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/pr201446","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/pr201446.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T06:19:16Z","timestamp":1746166756000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/pr201446"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,11]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["BFpr201446"],"URL":"https:\/\/doi.org\/10.1038\/pr.2014.46","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718349806.793494436","asserted-by":"object"}]},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,11]]}}}